Mercilon

Desogestrel, the active ingredient in Mercilon, is a combined oral contraceptive presented as an oral tablet for oral use. Together with ethinylestradiol, it works to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. GNH USA supplies Mercilon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Mercilon, a combined oral contraceptive, is indicated for hormonal contraception in women. - Prevention of pregnancy: provides reliable contraceptive protection when taken daily as directed. - Regulation of menstrual cycles: helps establish regular withdrawal bleeding and reduces cycle variability. - Treatment of acne: reduces acne lesions by decreasing androgenic activity on the skin. - Relief of premenstrual symptoms: lessens bloating, breast tenderness, and mood changes associated with PMS.

Like other combined oral contraceptives, Mercilon may be associated with a range of adverse reactions. Common Side Effects: - Nausea: mild to moderate stomach upset, especially during the first cycles. - Headache: tension‑type or migraine‑like headaches. - Breast tenderness: temporary swelling or soreness of the breasts. - Breakthrough bleeding: spotting or unscheduled bleeding between periods. Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs, requiring immediate medical attention. - Hypertension: significant increase in blood pressure that may need treatment. - Hepatic adenoma: rare benign liver tumor associated with long‑term estrogen exposure.

Before prescribing Mercilon, clinicians should evaluate several safety considerations. - Smoking status: avoid use in women over 35 who smoke due to increased thrombotic risk. - Cardiovascular history: contraindicated in patients with hypertension, coronary artery disease, or stroke. - History of thromboembolism: not recommended for women with prior deep‑vein thrombosis or pulmonary embolism. - Liver disease: use with caution in active liver disease or hepatic tumors. - Migraine with aura: contraindicated in women experiencing migraine with visual disturbances. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Mercilon can interact with several medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin, rifampicin): markedly reduce contraceptive hormone levels, risking breakthrough bleeding. - Antiretroviral protease inhibitors (e.g., ritonavir): may increase hormone concentrations, raising thrombotic risk. - St. John’s wort: herbal inducer that decreases plasma levels of ethinylestradiol and desogestrel. Moderate Interactions (Monitor Closely): - Antibiotics (e.g., tetracycline, metronidazole): may slightly diminish contraceptive effect; advise backup method. - Diuretics (e.g., thiazides): can increase blood pressure; monitor cardiovascular status. - Antifungal azoles (e.g., ketoconazole): may increase hormone levels; watch for signs of estrogen excess.